AGP Executive Report
Last update: 24 minutes agoHealth Tech & Safety: A Liechtenstein-linked PR scam is making the rounds: fake “Forbes” sites (including “Forbes Liechtenstein”) are packed with paid promotional posts, with AI-written pieces and hard-to-trace bylines; Forbes says the sites are fake and is taking action. Global Health & Drugs: Gan & Lee’s weight-loss drug deal is a big one for Europe: Menarini has bought rights to commercialize Bofenglutide for overweight/obesity across EU states plus Switzerland, Norway, Iceland, Liechtenstein and more, with upfront and milestone payments and royalties. Climate & Public Health: July 2026 is tied with July 2024 as the hottest month on record, raising the stakes for heat-related health risks. Local Health Policy: Liechtenstein’s regent, Prince Alois, says he will block any move to legalise abortion beyond current limits, noting many women still travel abroad for care. Wellness Lifestyle: If you’re planning a healthier routine while traveling, Bulgaria’s new digital nomad visa is being pitched as an affordable base for hiking and longer stays.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
